31 results on '"Frouni, Imane"'
Search Results
2. Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset
3. [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain
4. Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
5. The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
6. Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brain
7. Activation of mGlu2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism
8. Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat
9. Pharmacotherapy of Psychosis in Parkinson’s Disease
10. Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
11. Metabotropic glutamate receptors in Parkinson's disease
12. Cognition and serotonin in Parkinson's disease
13. Effect of the mGlu2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset.
14. Activation of mGlu2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism.
15. [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain.
16. Activation of mGlu2/3receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism
17. The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset.
18. Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.
19. The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
20. Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasma
21. Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat
22. Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
23. Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat.
24. Levodopa-induced dyskinesia: a brief review of the ongoing clinical trials
25. Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain
26. Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
27. Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain.
28. Activation of mGlu 2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism.
29. The 5-HT 2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.
30. Metabotropic glutamate receptors in Parkinson's disease.
31. Cognition and serotonin in Parkinson's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.